Stakeholders will expect more advanced data from specialty pharmacies managing patients with cancer, such as medical history, genetic markers, disease- and therapy-specific clinical outcomes, patient-reported outcomes, social determinants of health, specialty pharmacy interventions, adverse events, appeals, and reasons for therapy discontinuation, according to experts at the 2022 National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, in Orlando, Fla.
They will also expect